Meta AnalysisID 1869
香菇多糖联合顺铂胸腔内注射治疗肺癌：系统评价与Meta分析
CRD42020176544
To systematically evaluate the clinical effect of lentinan combined with cisplatin in the treatment of lung cancer patients.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 1869
- Evidence Id
- 10427
- Core Evidence Id
- 10427
- Source Meta Analysis Id
- 1813
- Herb2 Meta Analysis Id
- HBMA001813
- Crd Id
- CRD42020176544
- Title
- Lentinan combined with cisplatin for intrathoracic injection of lung cancer:a systematic review and meta-analyses
- Review Question
- To systematically evaluate the clinical effect of lentinan combined with cisplatin in the treatment of lung cancer patients.
- Study Type Included
- Language: English or Chinese each library database built between March 1, 2020, lentinan combined cisplatin chest RCT research study with drug treatment for lung cancer: lung cancer patients confirmed by pathology or cytology, western medicine diagnostic criteria and clinical staging in accordance with relevant guidelines and expert consensus [3-4, 8] interventions: the treatment group of lentinan combination chemotherapy regimens including cisplatin, compared with chemotherapy regimens including cisplatin, the treatment group and control group of chemotherapy regimens should be completely consistent, chemotherapy regimen and drug dosage unlimited outcome indicators: mainly includes the clinical efficacy of the quality of life safety, etc
- Condition Being Studied
- Oncology
- Participant
- The western medicine diagnostic criteria and clinical staging of lung cancer patients confirmed by pathology or cytology conform to relevant guidelines and expert consensus
- Animal
- Human Disease Modelled
- Intervention
- The treatment group was treated with lentinan combined with cisplatin chemotherapy
- Comparator Control
- The control group was treated with cisplatin chemotherapy
- Main Outcome
- NCCN Guidelinesew criteria of diagnosis and treatment for common malignant tumors\Guidelines for clinical diagnosis and treatment of lung cancer Measures of effect The measure of NCCN Guidelinesew criteria of diagnosis and treatment for common malignant tumors\Guidelines for clinical diagnosis and treatment of lung cancer must be tested before and after the intervention period. Reporting on the outcome is an inclusion criteria.
- Outcome Measure
- Additional Outcome
- Adverse event. Measures of effect Adverse events directly relating to the intervention will be reported if they occurred during the intervention of testing period. Reporting on this outcome is not an inclusion criteria.
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Cisplatin; Humans; Lentinan; Lung Neoplasms
- Contact
- Chenchen Zhao [email protected]
- Organisational Affiliation
- Tianjin University of Traditional Chinese Medicine
- Funding Source
- Major special project of science and technology for the prevention and treatment of chronic diseases of tianjin municipal science and technology commission (17ZXMFSY00190);Research project of tianjin municipal health and family planning commission on key areas of traditional Chinese medicine (2017003)Tianjin administration of traditional Chinese medicine (2019063)Tianjin education commission project (2018KJ015)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-03-28
- Registration Date
- 2020-04-28
- Anticipated Start Date
- 2019-12-01
- Anticipated Completion Date
- 2020-04-30
- Title Cn
- 香菇多糖联合顺铂胸腔内注射治疗肺癌：系统评价与Meta分析
- Title En
- Lentinan combined with cisplatin for intrathoracic injection of lung cancer:a systematic review and meta-analyses
- Bilingual Status
- complete